Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 3/20 | 0.37 |
| ▸ | RAPGEF4 | Q8WZA2 | 3/20 | 0.36 |
| ▸ | NOS3 | P29474 | 2/20 | 0.36 |
| ▸ | NOS1 | P29475 | 2/20 | 0.36 |
| ▸ | NOS2 | P35228 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22197813 | 0.86 | ALDH1A1 (0.47) | KDM4EALDH1A1TSHRTDP1CYP3A4 | |
| SCHEMBL139002 | 0.80 | ALDH1A1 (0.65) | KDM4EALDH1A1TSHRTDP1CYP3A4 | |
| SCHEMBL29066927 | 0.79 | CYP3A4 (0.43) | KDM4EALDH1A1TSHRTDP1CYP3A4 | |
| SCHEMBL30578150 | 0.77 | ALDH1A1 (0.61) | KDM4EALDH1A1TSHRTDP1CYP3A4 | |
| SCHEMBL30578152 | 0.77 | ALDH1A1 (0.61) | KDM4EALDH1A1TSHRTDP1CYP3A4 | |
| SCHEMBL28908462 | 0.77 | ALDH1A1 (0.61) | KDM4EALDH1A1TSHRTDP1CYP3A4 | |
| Methane SCHEMBL2038793 | 0.77 | ALDH1A1 (0.61) | KDM4EALDH1A1TSHRTDP1CYP3A4 | |
| Hydrochloric Acid SCHEMBL5621296 | 0.77 | ALDH1A1 (0.61) | KDM4EALDH1A1TSHRTDP1CYP3A4 | |
| Bromide SCHEMBL29858695 | 0.77 | ALDH1A1 (0.61) | KDM4EALDH1A1TSHRTDP1CYP3A4 | |
| SCHEMBL28217273 | 0.77 | ALDH1A1 (0.61) | KDM4EALDH1A1TSHRTDP1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119707773-A | Preparation method and application of maleimide structure-containing compound | 中国农业大学 | 2025-03-28 | — | — | CN | claimed |
| US-12344571-B1 | Organic color center-tailored, semiconducting carbon nanotubes and their method of manufacture | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2025-07-01 | — | — | US | disclosed |
| CN-119707773-A | Preparation method and application of maleimide structure-containing compound | 中国农业大学 | 2025-03-28 | — | — | CN | disclosed |
| CN-118754917-B | Alpha-diimine ligand compound, nickel complex, composite complex, preparation method and application thereof | 安徽中科科乐化工科技有限责任公司 | 2025-01-17 | — | — | CN | disclosed |
| EP-4122028-B1 | HETEROCYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2024-10-16 | — | — | EP | disclosed |
| CN-118754917-A | Alpha-diimine ligand compound, nickel complex, composite complex, preparation method and application thereof | 安徽中科科乐化工科技有限责任公司 | 2024-10-11 | — | — | CN | disclosed |
| CN-116836130-B | Synthesis method of 3, 4-dihydrobenzothiadiazine compound | 嘉实（湖南）医药科技有限公司 | 2023-11-21 | — | — | CN | disclosed |
| US-20230312613-A1 | HETEROCYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | UDC IRELAND LIMITED (IE) | 2023-10-05 | — | — | US | disclosed |
| CN-116836130-A | Synthesis method of 3, 4-dihydrobenzothiadiazine compound | 嘉实（湖南）医药科技有限公司 | 2023-10-03 | — | — | CN | disclosed |
| US-20230147279-A1 | HETEROCYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | UDC IRELAND LIMITED (IE) | 2023-05-11 | — | — | US | disclosed |
| WO-1997035578-A1 | TETRAHYDRO-BETA-CARBOLINE COMPOUNDS | ELI LILLY AND COMPANY (US) | 1997-10-02 | — | — | WO | disclosed |
| WO-1997035480-A1 | METHOD OF TREATING COMMON COLD OR ALLERGIC RHINITIS | ELI LILLY AND COMPANY (US) | 1997-10-02 | — | — | WO | disclosed |
| EP-0797995-A2 | Use of a 5-HT2 receptor antagonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis | ELI LILLY AND COMPANY (US) | 1997-10-01 | — | — | EP | disclosed |
| EP-0797994-A2 | Use of one or more 5-HT2 receptor antagonists in the manufacture of a medicament for treating the symptoms of venomous bites and stings | ELI LILLY AND COMPANY (US) | 1997-10-01 | — | — | EP | disclosed |
| US-5663178-A | 5-HT2 RECEPTOR ANTABONISTS | ELI LILLY AND COMPANY (US) | 1997-09-02 | — | — | US | disclosed |
| US-5643916-A | 5-HT(2B) RECEPTOR MODULATORS | ELI LILLY AND COMPANY (US) | 1997-07-01 | — | — | US | disclosed |
| US-5629317-A | SEROTONIN ANTAGONIST | ELI LILLY AND COMPANY (US) | 1997-05-13 | — | — | US | disclosed |
| EP-0749313-A1 | METHOD FOR TREATING 5HT 2B RECEPTOR RELATED CONDITIONS | ELI LILLY AND COMPANY (US) | 1996-12-27 | — | — | EP | disclosed |
| WO-1996024351-A1 | TETRAHYDRO-BETA-CARBOLINES, OCTAHYDRO-INDOLO-[2,3-c]QUINOLINES AND OCTAHYDRO-INDOLO-[2,3-c]-QUINUCLIDINES | ELI LILLY AND COMPANY (US) | 1996-08-15 | — | — | WO | disclosed |
| WO-1995024200-A1 | METHOD FOR TREATING 5HT2B RECEPTOR RELATED CONDITIONS | ELI LILLY AND COMPANY (US) | 1995-09-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230147279-A1 | HETEROCYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | DDT, VDAC2, KCNC1 | KDM4E 2547/4885ALDH1A1 649/4885TSHR 4593/4885 |
| US-20230312613-A1 | HETEROCYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | DDT, VDAC2, KCNC1 | KDM4E 2547/4885ALDH1A1 649/4885TSHR 4593/4885 |
| US-12344571-B1 | Organic color center-tailored, semiconducting carbon nanotubes and their method of manufacture | NOS1, NOS3, NOS2 | KDM4E 4548/4885ALDH1A1 754/4885TSHR 4597/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.